Scan to Download
One power score. Smarter investment decisions
TScan Therapeutics Inc
TCRX1.108USD
-0.027-2.40%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
62.87MMarket Cap
LossP/E TTM
TScan Therapeutics Inc
1.108
-0.027-2.40%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
Total revenue
473.88%3.08M
283.57%2.17M
-90.78%665.00K
-73.01%1.05M
-82.97%536.00K
-91.68%566.00K
132.99%7.21M
15.58%3.89M
-22.39%3.15M
125.19%6.80M
8.44%3.10M
39.43%3.36M
42.42%4.06M
49.04%3.02M
258.99%2.85M
731.72%2.41M
--2.85M
--2.03M
--795.00K
--290.00K
--0.00
--0.00
Revenue
473.88%3.08M
283.57%2.17M
-90.78%665.00K
-73.01%1.05M
-82.97%536.00K
-91.68%566.00K
132.99%7.21M
15.58%3.89M
-22.39%3.15M
125.19%6.80M
8.44%3.10M
39.43%3.36M
42.42%4.06M
49.04%3.02M
258.99%2.85M
731.72%2.41M
--2.85M
--2.03M
--795.00K
--290.00K
--0.00
--0.00
Operating expenses
20.43%41.73M
20.29%38.42M
30.84%37.38M
17.59%33.67M
24.83%34.65M
8.10%31.94M
31.38%28.57M
43.60%28.64M
43.81%27.76M
54.01%29.55M
27.49%21.74M
9.24%19.94M
42.69%19.30M
92.90%19.18M
98.21%17.06M
144.66%18.25M
140.87%13.53M
76.45%9.95M
--8.61M
--7.46M
--5.62M
--5.64M
R&D expenses
19.48%32.11M
17.82%29.29M
31.01%29.35M
15.48%26.26M
26.62%26.88M
14.13%24.86M
43.59%22.41M
51.29%22.74M
46.45%21.23M
48.26%21.78M
23.76%15.60M
5.81%15.03M
34.19%14.49M
100.16%14.69M
111.40%12.61M
144.38%14.21M
139.92%10.80M
70.75%7.34M
--5.96M
--5.81M
--4.50M
--4.30M
Depreciation, depletion, and amortization
-37.46%698.00K
-45.93%678.00K
-44.45%711.00K
-20.14%1.03M
-13.89%1.12M
-16.34%1.25M
-13.75%1.28M
2.80%1.29M
7.37%1.30M
25.44%1.50M
29.95%1.48M
18.47%1.25M
82.60%1.21M
154.80%1.20M
188.38%1.14M
205.20%1.06M
148.50%661.00K
111.26%469.00K
--396.00K
--346.00K
--266.00K
--222.00K
Operating profit
-13.31%-38.65M
-15.55%-36.25M
-71.90%-36.71M
-31.82%-32.62M
-38.62%-34.11M
-37.95%-31.37M
-14.52%-21.36M
-49.28%-24.75M
-61.42%-24.61M
-40.71%-22.74M
-31.31%-18.65M
-4.65%-16.58M
-42.77%-15.25M
-104.13%-16.16M
-81.84%-14.20M
-120.92%-15.84M
-90.15%-10.68M
-40.49%-7.92M
---7.81M
---7.17M
---5.62M
---5.64M
Net non-operating interest income (expenses)
Non-operating interest income
-29.81%2.39M
27.95%2.80M
6.97%2.78M
35.13%3.69M
121.97%3.41M
92.78%2.19M
188.12%2.60M
411.80%2.73M
929.53%1.53M
16128.57%1.14M
44950.00%901.00K
17700.00%534.00K
2880.00%149.00K
16.67%7.00K
-33.33%2.00K
200.00%3.00K
66.67%5.00K
-93.94%6.00K
--3.00K
--1.00K
--3.00K
--99.00K
Non-operating interest expense
-27.63%689.00K
-29.20%679.00K
-7.98%784.00K
-2.44%958.00K
-1.75%952.00K
0.31%959.00K
-12.62%852.00K
388.56%982.00K
--969.00K
--956.00K
--975.00K
--201.00K
----
----
----
----
----
----
----
----
----
----
Special income (expenses)
----
----
---1.09M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income before tax
-16.71%-36.95M
-13.22%-34.13M
-82.58%-35.81M
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-4.75%-19.61M
-41.56%-23.00M
-59.27%-24.05M
-39.66%-22.56M
-31.85%-18.72M
-2.56%-16.25M
-41.44%-15.10M
-104.20%-16.16M
-81.89%-14.20M
-120.91%-15.84M
-90.17%-10.67M
-42.89%-7.91M
---7.81M
---7.17M
---5.61M
---5.54M
Income after tax
-16.71%-36.95M
-13.22%-34.13M
-82.58%-35.81M
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-4.75%-19.61M
-41.56%-23.00M
-59.27%-24.05M
-39.66%-22.56M
-31.85%-18.72M
-2.56%-16.25M
-41.44%-15.10M
-104.20%-16.16M
-81.89%-14.20M
-120.91%-15.84M
-90.17%-10.67M
-42.89%-7.91M
---7.81M
---7.17M
---5.61M
---5.54M
Net income from continuous operations
-16.71%-36.95M
-13.22%-34.13M
-82.58%-35.81M
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-4.75%-19.61M
-41.56%-23.00M
-59.27%-24.05M
-39.66%-22.56M
-31.85%-18.72M
-2.56%-16.25M
-41.44%-15.10M
-104.20%-16.16M
-81.89%-14.20M
-120.91%-15.84M
-90.17%-10.67M
-42.89%-7.91M
---7.81M
---7.17M
---5.61M
---5.54M
Net income attributable to controlling interests
-16.71%-36.95M
-13.22%-34.13M
-82.58%-35.81M
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-4.75%-19.61M
-41.56%-23.00M
-59.27%-24.05M
-39.66%-22.56M
-31.85%-18.72M
-2.56%-16.25M
-41.44%-15.10M
-104.20%-16.16M
-81.89%-14.20M
-120.91%-15.84M
-90.17%-10.67M
-42.89%-7.91M
---7.81M
---7.17M
---5.61M
---5.54M
Net income attributable to common shareholders
-16.71%-36.95M
-13.22%-34.13M
-82.58%-35.81M
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-4.75%-19.61M
-41.56%-23.00M
-59.27%-24.05M
-39.66%-22.56M
-31.85%-18.72M
-2.56%-16.25M
-41.44%-15.10M
-104.20%-16.16M
-81.89%-14.20M
-120.91%-15.84M
-90.17%-10.67M
-42.89%-7.91M
---7.81M
---7.17M
---5.61M
---5.54M
Basic earnings per share
-2.04%-0.28
17.16%-0.26
-43.92%-0.30
-3.83%-0.25
45.19%-0.28
65.89%-0.32
73.52%-0.21
64.06%-0.24
18.82%-0.51
-38.21%-0.93
-29.17%-0.78
-0.49%-0.67
-38.64%-0.63
-100.90%-0.67
-81.89%-0.60
-120.91%-0.67
-90.17%-0.45
-42.89%-0.34
---0.33
---0.30
---0.24
---0.23
Diluted earnings per share
-2.04%-0.28
17.16%-0.26
-43.92%-0.30
-3.83%-0.25
45.19%-0.28
65.89%-0.32
73.52%-0.21
64.06%-0.24
18.82%-0.51
-38.21%-0.93
-29.17%-0.78
-0.49%-0.67
-38.64%-0.63
-100.90%-0.67
-81.89%-0.60
-120.91%-0.67
-90.17%-0.45
-42.89%-0.34
---0.33
---0.30
---0.24
---0.23
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
